Diabetic Retinopathy and Diabetic Eye Disease Typically thought of as a retinal microvascular disease, diabetic retinopathy (DR) is also a retinal neurodegenerative process
G., Whitcher, J
GLP-1 medications are typically considered for adults who: Have a Body Mass Index (BMI) of 30 or higher Have a BMI of 27 or higher with weight-related conditions such as diabetes or hypertension Have not achieved sustained weight loss through lifestyle modification alone These medications are intended for long-term weight management, not short-term or cosmetic weight loss
The questions that matter more, and the ones I get less often, are the ones this article is built to answer: how do these medications actually differ, who should choose which one, what should you expect from treatment, and how do you tell a careful clinical program apart from a prescription mill
It is commonly dosed at 1-2mg/daily over 10 days, followed by a maintenance dose [5]
Cycling is recommended to prevent GHS receptor desensitization